Filings/CTMX/IR

CYTOMX THERAPEUTICS, INC. IR

financial tables · 2018

Designing In and Around Tolerability Considerations for Immunotherapy Combinations

Source document

Issuer site
Loading document…
Designing In and Around Tolerability Considerations for Immunotherapy Combinations — CYTOMX THERAPEUTICS, INC.